Annual FCF
-$40.03 M
-$4.53 M-12.75%
December 31, 2023
Summary
- As of February 8, 2025, VIRX annual free cash flow is -$40.03 million, with the most recent change of -$4.53 million (-12.75%) on December 31, 2023.
- During the last 3 years, VIRX annual FCF has fallen by -$23.92 million (-148.49%).
- VIRX annual FCF is now -148.49% below its all-time high of -$16.11 million, reached on December 31, 2020.
Performance
VIRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$7.09 M
+$2.73 M+27.82%
September 30, 2024
Summary
- As of February 8, 2025, VIRX quarterly free cash flow is -$7.09 million, with the most recent change of +$2.73 million (+27.82%) on September 30, 2024.
- Over the past year, VIRX quarterly FCF has increased by +$2.93 million (+29.26%).
- VIRX quarterly FCF is now -378.05% below its all-time high of $2.55 million, reached on March 31, 2021.
Performance
VIRX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$34.80 M
+$3.39 M+8.88%
September 30, 2024
Summary
- As of February 8, 2025, VIRX TTM free cash flow is -$34.80 million, with the most recent change of +$3.39 million (+8.88%) on September 30, 2024.
- Over the past year, VIRX TTM FCF has increased by +$5.23 million (+13.08%).
- VIRX TTM FCF is now -851.23% below its all-time high of -$3.66 million, reached on March 31, 2020.
Performance
VIRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
VIRX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.8% | +29.3% | +13.1% |
| 3 y3 years | -148.5% | +29.3% | +13.1% |
| 5 y5 years | -148.5% | +29.3% | +13.1% |
VIRX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -73.3% | at low | at high | +37.6% | -50.6% | +13.1% |
| 5 y | 5-year | -148.5% | at low | -378.1% | +40.0% | -851.2% | +13.1% |
| alltime | all time | -148.5% | at low | -378.1% | +40.0% | -851.2% | +13.1% |
Viracta Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.09 M(-27.8%) | -$34.80 M(-8.9%) |
| Jun 2024 | - | -$9.83 M(+25.2%) | -$38.19 M(+4.5%) |
| Mar 2024 | - | -$7.85 M(-21.7%) | -$36.54 M(-8.7%) |
| Dec 2023 | -$40.03 M(+12.8%) | -$10.03 M(-4.4%) | -$40.03 M(+5.6%) |
| Sep 2023 | - | -$10.48 M(+28.2%) | -$37.91 M(+9.6%) |
| Jun 2023 | - | -$8.18 M(-27.9%) | -$34.58 M(-2.5%) |
| Mar 2023 | - | -$11.34 M(+43.5%) | -$35.48 M(-0.1%) |
| Dec 2022 | -$35.50 M | -$7.90 M(+10.4%) | -$35.50 M(+1.9%) |
| Sep 2022 | - | -$7.16 M(-21.2%) | -$34.83 M(-11.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$9.08 M(-20.1%) | -$39.50 M(+6.7%) |
| Mar 2022 | - | -$11.36 M(+57.2%) | -$37.02 M(+60.2%) |
| Dec 2021 | -$23.10 M(+43.4%) | -$7.23 M(-38.9%) | -$23.10 M(+13.2%) |
| Sep 2021 | - | -$11.83 M(+79.2%) | -$20.41 M(+58.9%) |
| Jun 2021 | - | -$6.60 M(-358.6%) | -$12.85 M(+29.8%) |
| Mar 2021 | - | $2.55 M(-156.2%) | -$9.90 M(-38.5%) |
| Dec 2020 | -$16.11 M | -$4.54 M(+6.6%) | -$16.11 M(+39.3%) |
| Sep 2020 | - | -$4.26 M(+16.7%) | -$11.57 M(+58.3%) |
| Jun 2020 | - | -$3.65 M(-0.2%) | -$7.31 M(+99.8%) |
| Mar 2020 | - | -$3.66 M | -$3.66 M |
FAQ
- What is Viracta Therapeutics annual free cash flow?
- What is the all time high annual FCF for Viracta Therapeutics?
- What is Viracta Therapeutics annual FCF year-on-year change?
- What is Viracta Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly FCF year-on-year change?
- What is Viracta Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Viracta Therapeutics?
- What is Viracta Therapeutics TTM FCF year-on-year change?
What is Viracta Therapeutics annual free cash flow?
The current annual FCF of VIRX is -$40.03 M
What is the all time high annual FCF for Viracta Therapeutics?
Viracta Therapeutics all-time high annual free cash flow is -$16.11 M
What is Viracta Therapeutics annual FCF year-on-year change?
Over the past year, VIRX annual free cash flow has changed by -$4.53 M (-12.75%)
What is Viracta Therapeutics quarterly free cash flow?
The current quarterly FCF of VIRX is -$7.09 M
What is the all time high quarterly FCF for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly free cash flow is $2.55 M
What is Viracta Therapeutics quarterly FCF year-on-year change?
Over the past year, VIRX quarterly free cash flow has changed by +$2.93 M (+29.26%)
What is Viracta Therapeutics TTM free cash flow?
The current TTM FCF of VIRX is -$34.80 M
What is the all time high TTM FCF for Viracta Therapeutics?
Viracta Therapeutics all-time high TTM free cash flow is -$3.66 M
What is Viracta Therapeutics TTM FCF year-on-year change?
Over the past year, VIRX TTM free cash flow has changed by +$5.23 M (+13.08%)